This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Explore the resources outlined below to gain further insights into EYLEA® 8mg (114.3 mg/ml aflibercept) in neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular oedema (DME).

PFS Image

Key steps for preparing and injecting OcuClick®

Below you will find the key steps that must be followed when preparing for intravitreal injection using OcuClick. Always consult the OcuClick instructions for use (IFU) card, which provides more detail for each step.

Dosing Guide - Eylea

Flexible Dosing Options

Dosing regimens in nAMD and DME

Insurance Code Thumbnail

Eylea® 8mg - Insurance Claim Codes

Contains codes for major Irish insurance organisations

PP-EYL_8mg-IE-0162-1   |   December 2025